TP53 and lymphoma: Notably, in the MYC or MYC p53−/−, but not in MYC p19ARF−/− lymphomas, differences were found in a senescence/cell aging pathway, macrophage activation/infiltration and innate immune cell activation/infiltration pathways (Figure 6C).